Model 486-05 Polyflex Implantable Pacing Lead
by Intermedics, Inc. 510(k)
Active
510(k) K864564
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK864564 | Date5 Dec 1986 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- Full name
- Model 486-05 Polyflex(R) Implantable Pacing Lead
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Model 486-05 Polyflex Implantable Pacing Lead is a Permanent Pacemaker Electrode, designed for cardiac pacing applications. It delivers electrical impulses to regulate heart rhythm in patients with bradycardia or conduction disorders, ensuring consistent atrial or ventricular stimulation via an implanted lead system.
This device is intended for single-use implantation within the cardiovascular system and is classified as Class III under FDA regulations. Sterilized via ethylene oxide, it is supplied sterile and requires surgical implantation by a qualified healthcare professional. The lead is compatible with MRI environments under specific conditions as outlined in its labeling, and its design includes a 3002618605 reference code for regulatory tracking.
Other devices from Intermedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
Is the Model 486-05 Polyflex Implantable Pacing Lead reusable or intended for single-use only?
The Model 486-05 Polyflex Implantable Pacing Lead is explicitly designed for single-use implantation within the cardiovascular system. It is supplied sterile via ethylene oxide sterilization and is not intended for reuse after implantation.
What types of heart conditions is this pacing lead intended to address?
This lead is intended for cardiac pacing applications, specifically to regulate heart rhythm in patients with bradycardia or conduction disorders. It delivers electrical impulses to ensure consistent atrial or ventricular stimulation via an implanted lead system.
How is this device sterilized, and what precautions should be taken during handling?
The Model 486-05 Polyflex Implantable Pacing Lead is sterilized using ethylene oxide, ensuring it is supplied in a sterile condition. Since it is intended for surgical implantation, it must be handled under aseptic conditions by qualified healthcare professionals to maintain sterility until use.
Can this lead be used in patients who require MRI scans, and if so, under what conditions?
The lead is compatible with MRI environments under specific conditions, as outlined in its labeling. However, the exact parameters (e.g., MRI strength, safety protocols) are not detailed in the provided data, so clinicians should refer to the device’s official labeling or manufacturer instructions for precise MRI compatibility guidelines.
What regulatory pathway was followed for this device’s approval, and what classification does it hold?
The Model 486-05 Polyflex Implantable Pacing Lead was cleared through the FDA’s 510(k) Traditional pathway and is classified as a Class III device under FDA regulations. It was determined to be substantially equivalent to a predicate device, with the clearance filed in 1986 under the Cardiovascular (CV) Advisory Committee.